Cargando…
Use of Obesity Biomarkers in Cardiovascular Epidemiology
Obesity is an established risk factor for cardiovascular disease (CVD), yet, the underlying mechanisms are only poorly understood. The adipose tissue produces a variety of hormones and cytokines and thereby actively participates in a network of biomarkers that may be relevant for the development of...
Autor principal: | Pischon, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833608/ https://www.ncbi.nlm.nih.gov/pubmed/19773614 http://dx.doi.org/10.3233/DMA-2009-0634 |
Ejemplares similares
Ejemplares similares
-
Myocardial Biomarkers for Prediction of Cardiovascular Disease
por: Sundström, Johan
Publicado: (2009) -
Evaluating the Prognostic Value of New Cardiovascular Biomarkers
por: Wood, Angela M., et al.
Publicado: (2009) -
Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk
por: Aleksandrova, Krasimira, et al.
Publicado: (2012) -
Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
por: Cai, Anping, et al.
Publicado: (2013) -
The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
por: Davidsson, Pia, et al.
Publicado: (2005)